Acadia Pharmaceuticals Inc.

Alma Fejzic

Nathalie Schlienger

Jan Pawlas

Carl-Magnus A Andersson

Eva Louise Hansen

Roger Olsson

Mikkel Boas Thygesen

Birgitte Winther Lund

Fabrizio Badalassi

Rasmus Lewinsky

Disclosed herein are compounds of Formula I, or a pharmaceutically acceptable salt, amide, ester, or prodrug thereof. Also disclosed are methods of inhibiting an activity of a monoamine receptor comprising contacting the monoamine receptor or a system containing the monoamine receptor with an effective amount of one or more of the compounds of Formula I. Disclosed are also methods of inhibiting an activation of a monoamine receptor comprising contacting the monoamine receptor or a system containing the monoamine receptor with an effective amount of one or more of the compounds of Formula I. Furthermore, methods of treating psychotic disease using a compound of Formula I are disclosed.

N-substituted piperidine derivatives as serotonin receptor agents

Disclosed herein are bicycloaryl compounds of Formula (I) that selectively modulate nuclear receptors, preferably the androgen receptor, or a pharmaceutically acceptable salt, ester, amide, or prodrug thereof, and methods of treating disease comprising administering a compound of Formula (I) to a patient in need thereof.

Androgen receptor modulators and method of treating disease using the same

Growing community of inventors

Frederiksberg, Denmark

Alma Fejzic